open access

Vol 48, No 3 (2017)
Prace poglądowe / Reviews
Published online: 2017-07-01
Submitted: 2017-07-07
Get Citation

Risk of transmission of blood-derived pathogens by transfusion in Poland

Piotr Grabarczyk, Aneta Kopacz1, Ewa Sulkowska1, Aleksandra Kalińska1
DOI: 10.1016/j.achaem.2017.07.006
·
Acta Haematol Pol 2017;48(3):174-182.
Affiliations
  1. Zakład Wirusologii, Instytut Hematologii i Transfuzjologii w Warszawie, Polska

open access

Vol 48, No 3 (2017)
Prace poglądowe / Reviews
Published online: 2017-07-01
Submitted: 2017-07-07

Abstract

Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum.

In this article, we discuss the improvement of the epidemic situation among blood donors for hepatitis B virus (HBV) and hepatitis C virus (HCV) and the increasing trend for HIV. Preliminary results of residual risk calculation for these pathogens are presented.

Hepatitis E virus (HEV) and Babesia microti were considered as new factors potentially relevant for the safety of blood transfusion in our country. Due to evidence of West Nile virus (WNV) circulation in the ecosystem in Poland, it is also necessary to monitor the infections with this pathogen.

In this article, it was emphasized that the reporting of all possible complications associated with transfusion and meticulous implementation of the look-back procedure play a key role for monitoring the risk of transmission of infectious agents by blood. It is especially important in view of the increasing epidemiological problems associated with emerging infectious agents.

Abstract

Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum.

In this article, we discuss the improvement of the epidemic situation among blood donors for hepatitis B virus (HBV) and hepatitis C virus (HCV) and the increasing trend for HIV. Preliminary results of residual risk calculation for these pathogens are presented.

Hepatitis E virus (HEV) and Babesia microti were considered as new factors potentially relevant for the safety of blood transfusion in our country. Due to evidence of West Nile virus (WNV) circulation in the ecosystem in Poland, it is also necessary to monitor the infections with this pathogen.

In this article, it was emphasized that the reporting of all possible complications associated with transfusion and meticulous implementation of the look-back procedure play a key role for monitoring the risk of transmission of infectious agents by blood. It is especially important in view of the increasing epidemiological problems associated with emerging infectious agents.

Get Citation

Keywords

HCV; HBV; HIV; HEV; Babesia microti; Transfusion-transmitted pathogens

About this article
Title

Risk of transmission of blood-derived pathogens by transfusion in Poland

Journal

Acta Haematologica Polonica

Issue

Vol 48, No 3 (2017)

Pages

174-182

Published online

2017-07-01

DOI

10.1016/j.achaem.2017.07.006

Bibliographic record

Acta Haematol Pol 2017;48(3):174-182.

Keywords

HCV
HBV
HIV
HEV
Babesia microti
Transfusion-transmitted pathogens

Authors

Piotr Grabarczyk
Aneta Kopacz
Ewa Sulkowska
Aleksandra Kalińska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl